Used in testosterone replacement therapy (TRT) for male hypogonadism, delayed puberty in males, and certain breast cancers in women.

Acne, mood changes, increased red blood cell count, fluid retention, potential risk of prostate enlargement or cardiovascular events.

Monitor prostate health, hematocrit, and lipid levels; use cautiously in those with cardiovascular or liver disease.

Prostate or breast cancer in men, severe liver or kidney disease, pregnancy, known hypersensitivity to testosterone.

Varies by form: 50–100 mg IM weekly; 5–10 g daily of gel; or 4–6 mg/day via patches.

Mexico, Brazil, Colombia

Intramuscular injections, transdermal gels and patches, subcutaneous pellets, oral capsules, buccal tablets.